March 7th 2024
Differences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.
Understanding Which Risk Factors for Osteoporosis Can Change
December 25th 2018Which risk factors of osteoporosis can be modified, and which cannot? With osteoporosis causing more than 9 million fractures globally, understanding how to prevent it can reduce this growing threat to a rapidly aging population, researchers recently reported.
Read More
Osteoporosis Working Group Creates Recommendations for Economic Evaluations
December 15th 2018A working group of osteoporosis experts established recommendations for the design and conduct of economic evaluations in osteoporosis, as well as guidance for reporting these evaluations. The group also created a set of minimum criteria for evaluations and an osteoporosis-specific checklist of items to incorporate in economic reports.
Read More
Osteoporosis Screening Strategies Don't Identify Younger Women at Risk
December 15th 2018Current screening for women between ages 50 and 64 for osteoporosis needs improvement, according to a recent comparison of treatment and screening strategies from different organizations in the United States and Canada.
Read More
Persistent Osteoporosis Medication Use Is Associated With Less Fracture Risk
December 5th 2018The use of osteoporosis medication for 12 months reduced the risk of fractures and decreased medical costs in elderly female Medicare beneficiaries with osteoporosis, according to the results of a recent study.
Read More
What Are The Factors That Influence Adherence to Medications for Osteoporosis?
November 30th 2018Despite the fact that osteoporosis is a growing public health problem in the United States and worldwide, there is poor adherence to medications to treat the problem. A recent study published in Osteoporosis International identified the factors that influence patient adherence to therapy, many of which are modifiable.
Read More
Thyroid-Stimulating Hormone Suppression Does Not Significantly Affect Bone Mineral Density
November 21st 2018No significant differences in bone mineral density (BMD) were observed between patients with differentiated thyroid carcinoma (DTC) who received thyroid-stimulating hormone suppression (TSHS) and those who did not, according to a recent study.
Read More
Denosumab Appears to Help Patients With Transfusion-Dependent Thalassemia, Osteoporosis
November 13th 2018Patients with transfusion-dependent thalassemia (TDT) and osteoporosis who were treated with denosumab had greater increases in bone mineral density in the femoral neck and lumbar spine, as well as lower pain scores and bone resorption biomarkers, compared with placebo, according to the results of a phase 2b trial.
Read More
Alendronate for Glucocorticoid-Induced Osteoporosis Does Not Reduce Fracture Risk
November 10th 2018A recent review of alendronate for the treatment of glucocorticoid-induced osteoporosis (GIO) found that it significantly increased bone mineral density of the lumbar spine and femoral neck in patients with GIO, but does not appear to reduce the risk of fractures.
Read More
Calcaneal Quantitative Ultrasound May Serve as a Prescreening Tool for Osteoporosis
November 3rd 2018Calcaneal quantitative ultrasound (QUS) has comparable diagnostic accuracy as dual-energy x-ray absorptiometry (DXA), the gold standard for diagnosing osteoporosis. Although it cannot replace DXA for diagnosing osteoporosis, it can be used as an effective prescreening tool prior to a DXA scan, researchers said it a recent study comparing the performance of the 2 screening methods.
Read More
Cataracts Linked to Higher Risk of Osteoporosis, Fracture
October 30th 2018A recent study from Taiwan found that having cataracts was independently associated with increased risks of osteoporosis and fracture, and there also might be an association between cataract surgery and lower risks of osteoporosis and fracture.
Read More
Comparing Effectiveness of Osteoporosis Drugs on Risk of Fracture in 2 Countries
October 26th 2018Researchers aimed to compare the clinical effectiveness of oral anti-osteoporosis drugs based on the observed risk of fracture while receiving treatment through primary care in the United Kingdom and Spain.
Read More
Timing of Low Molecular Weight Heparin Does Not Affect Mortality in Hip Fracture Surgery
October 23rd 2018Postoperative and preoperative start of low molecular weight heparin (LMWH) does not change the outcome of mortality or risk of reoperation in patients with hip fractures treated with osteosynthesis, according to a recent study.
Read More
Selective Estrogen Receptor Modulators Have Higher Reduced Hip Fracture Risk Than Alendronate
October 19th 2018A retrospective cohort study by compared different osteoporosis preventative-medications and found that selective estrogen receptor modulators (SERM) had better hip and major fracture risk reductions than alendronate, while strontium ranelate (SR) had poorer hip and major fracture risk reduction than alendronate.
Read More
Large Review Finds Vitamin D Ineffective in Preventing Fractures, Falls
October 16th 2018A large meta-analysis did not find any beneficial effects to vitamin D supplementation for reducing fractures, falls, and bone mineral density, according to a recent study published in The Lancet Diabetes and Endocrinology.
Read More
Six-Year Study of Zoledronate for Osteopenia Shows Reduction in Fragility Fractures
October 10th 2018Giving zoledronate every 18 months for 6 years reduced the risk of fragility fractures—both vertebral and nonvertebral—in older women with hip bone mineral density indicating osteopenia, a recent study published in The New England Journal of Medicine reported.
Read More
ASBMR's Updated Osteoporosis Guidelines Emphasize Communication to Avoid Secondary Fractures
October 8th 2018The decline in fractures caused by osteoporosis has stagnated, leading bone experts to suspect a lack in osteoporosis diagnosis and treatment guideline adherence. To combat this, the American Society for Bone and Mineral Research (ASBMR) has added 5 clinical care recommendations to prevent secondary fractures in at-risk patients.
Read More
Statin Use Cut Risk of Osteoporosis, Fractures, Study Finds
September 25th 2018A recent study found that statin use reduced the risks of osteoporosis, hip fracture, and vertebral fracture in stroke patients by 30% to 40%, and a dose-effect relationship was observed between statin cumulative defined daily doses and decreased risks of osteoporosis and fractures.
Read More
Researchers Struggle to Define Quality Indicators for Hip Fracture
September 22nd 2018Hip fractures (HF) are one of the most common injuries seen in emergency departments among the elderly, but quality care measures for hip fractures are lacking. To that end, a recent report sought to identify optimal quality indicators (QI) for clinical use, but researchers found gaps that need to be addressed.
Read More